Synthesis, and Cytotoxic Activity of Novel Pyrazoline-Thiazolidinone Derivatives with Molecular Docking Studies

References

• E. Toja, A. Depaoli, G. Tuan, and J. Kettenring, “Synthesis of 2-Amino-3-Ethoxycarbonylpyrroles,” Synthesis 1987, no. 03 (1987): 272–4.
   Google Scholar
• J. M. Muchowski, S. H. Unger, J. Ackrell, P. Cheung, G. F. Cooper, J. Cook, P. Gallegra, O. Halpern, R. Koehler, and A. F. Kluge, “Synthesis and Antiinflammatory and Analgesic Activity of 5-Aroyl-1,2-Dihydro-3H-Pyrrolo[1,2-a]Pyrrole-1-Carboxylic Acids and Related Compounds,” Journal of Medicinal Chemistry 28, no. 8 (1985): 1037–49.
   PubMed Web of Science ®Google Scholar
• G. Dannhardt, W. Kiefer, G. Kramer, S. Maehrlein, U. Nowe, and B. Fiebich, “The Pyrrole Moiety as a Template for COX-1/COX-2 Inhibitors,” European Journal of Medicinal Chemistry 35, no. 5 (2000): 499–510.
   PubMed Web of Science ®Google Scholar
• I. K. Khanna, R. M. Weier, Y. Yu, P. W. Collins, J. M. Miyashiro, C. M. Koboldt, A. W. Veenhuizen, J. L. Currie, K. Seibert, and P. C. Isakson, “1,2-Diarylpyrroles as Potent and Selective Inhibitors of Cyclooxygenase-2,” Journal of Medicinal Chemistry 40, no. 11 (1997): 1619–33.
   PubMed Web of Science ®Google Scholar
• B. S. Burnham, J. T. Gupton, K. E. Krumpe, T. Webb, J. Shuford, B. Bowers, A. E. Warren, C. Barnes, and I. H. Hall, “Cytotoxicity of Substituted Alkyl-3,4-Bis(4-Methoxyphenyl)Pyrrole-2-Carboxylates in L1210 Lymphoid Leukemia Cell S,” Archiv Der Pharmazie 331, no. 11 (1998): 337–41.
   PubMed Web of Science ®Google Scholar
• J. T. Gupton, B. S. Burham, B. D. Byrd, K. E. Krumpe, C. Stokes, J. Shuford, S. Winkle, T. Webb, A. E. Warren, C. R. Barnes, et al, “The Cytotoxicity and Mode of Action of 2,3,4-Trisubstituted Pyrroles and Related Derivatives in Human Tmolt4 Leukemia Cells,” Die Pharmazie 54, no. 9 (1999): 691–7.,
   PubMed Web of Science ®Google Scholar
• Justin M. Holub, Kathy O'Toole-Colin, Adam Getzel, Anthony Argenti, Michael A. Evans, Daniel C. Smith, Gerard A. Dalglish, Shahzad Rifat, Donna L. Wilson, Brett M. Taylor, et al, “Lipid-Lowering Effects of Ethyl 2-Phenacyl-3-Aryl-1H-Pyrrole- 4-Carboxylates in Rodents,” Molecules (Basel, Switzerland) 9, no. 3 (2004): 134–57.,
   PubMed Web of Science ®Google Scholar
• K. Krowicki, J. Balzarini, E. De Clercq, R. A. Newman, and J. W. Lown, “Novel DNA Groove Binding Alkylators: design, Synthesis, and Biological Evaluation,” Journal of Medicinal Chemistry 31, no. 2 (1988): 341–5.
   PubMed Web of Science ®Google Scholar
• A. M. Almerico, P. Diana, P. Barraja, G. Dattolo, F. Mingoia, A. G. Loi, F. Scintu, C. Milia, I. Puddu, and P. La Colla, “Glycosidopyrroles. Part 1. Acyclic Derivatives: 1-(2-Hydroxyethoxy)Methylpyrroles as Potential anti-Viral Agents,” Farmaco (Societa Chimica Italiana : 1989) 53, no. 1 (1998): 33–40.
   PubMedGoogle Scholar
• Humberto Carpio, Edvige Galeazzi, Robert Greenhouse, Angel Guzmán, Esperanza Velarde, Yulia Antonio, Fidencio Franco, Alicia Leon, Virginia Pérez, Raquel Salas, et al, “Synthesis of l,2-Dihydro-3 H -Pyrrolo[1,2- a] Pyrrole-1-Carboxylic Acids and Homologous Pyridine and Azepine Analogues Thereof,” Canadian Journal of Chemistry 60, no. 18 (1982): 2295–312.,
   Web of Science ®Google Scholar
• Michael A. Evans, Daniel C. Smith, Justin M. Holub, Anthony Argenti, Mafoloe Hoff, Gerard A. Dalglish, Donna L. Wilson, Brett M. Taylor, Joshua D. Berkowitz, Bruce S. Burnham, et al, “Synthesis and Cytotoxicity of Substituted Ethyl 2-Phenacyl-3-Phenylpyrrole-4-Carboxylates,” Archiv Der Pharmazie 336, no. 3 (2003): 181–90.
   PubMed Web of Science ®Google Scholar
• S. I. Elewa, E. Mansour, I. F. Nassar, and A. A. I. Mekawey, “Synthesis of Some New Pyrazoline-Based Thiazole Derivatives and Evaluation of Their Antimicrobial, Antifungal, and Anticancer Activities,” Russian Journal of Bioorganic Chemistry 46, no. 3 (2020): 382–92.
   Web of Science ®Google Scholar
• E. Mansour, A. Aboelnaga, E. M. Nassar, and S. I. Elewa, “A New Series of Thiazolyl Pyrazoline Derivatives Linked to Benzo[1,3]Dioxole Moiety: Synthesis and Evaluation of Antimicrobial and anti-Proliferative Activities,” Synthetic Communications 50, no. 3 (2020): 368–79.
   Web of Science ®Google Scholar
• H. A. Bdel-Aziz, H. S. El-Zahabi, and K. M. Dawood, “Microwave-Assisted Synthesis and inVitro anti-Tumor Activity of 1, 3, 4-Triaryl-5-N-Arylpyrazole-Carboxamides,” European Journal of Medicinal Chemistry. 45, no. 6 (2010): 2427–32.
   PubMed Web of Science ®Google Scholar
• S. M. Gomha, S. M. Riyadh, E. A. Mahmmoud, and M. M. Elaasser, “Synthesis and Anticancer Activities of Thiazoles, 1, 3-Thiazines, and Thiazolidine Using ChitosanGrafted-Poly (Vinylpyridine) as Basic Catalyst,” Heterocycles 91, no. 6 (2015): 1227–43.
   Web of Science ®Google Scholar
• P. Karegoudar, M. S. Karthikeyan, D. J. Prasad, M. Mahalinga, B. S. Holla, and N. S. Kumari, “Synthesis of Some Novel 2,4-Disubstituted Thiazoles as Possible Antimicrobial Agents,” European Journal of Medicinal Chemistry 43, no. 2 (2008): 261–7.
   PubMed Web of Science ®Google Scholar
• S. M. Gomha, N. A. Kheder, M. R. Abdelaziz, Y. N. Mabkhot, and A. M. A. Alhajoj, “Facile Synthesis and Anticancer Activity of Some Novel Thiazoles Carrying 1,3,4-Thiadiazole Moiety,” Chemistry Central Journal 11, no. 1 (2017): 25.
   PubMedGoogle Scholar
• S. M. Gomha, and H. A. Abdel-Aziz, “Synthesis of New Heterocycles Derived from 3-(3- Methyl-1H-Indol-2-yl)-3-Oxopropanenitrile as Potent Antifungal Agents,” Bulletin of the Korean Chemical Society. 33, no. 9 (2012): 2985–90.
   Web of Science ®Google Scholar
• N. A. Kheder, S. M. Riyadh, and A. M. Asiry, “Azoles and Bis-Azoles: Synthesis and Biological Evaluation as Antimicrobial and anti-Cancer Agents,” Chemical & Pharmaceutical Bulletin 61, no. 5 (2013): 504–10. 378 E. MANSOUR ET AL.
   PubMed Web of Science ®Google Scholar
• P. Kumar, N. Chandak, P. Kaushik, C. Sharma, D. Kaushik, K. R. Aneja, and P. K. Sharma, “Synthesis and Biological Evaluation of Some Pyrazole Derivatives as AntiInflammatory–Antibacterial Agents,” Medicinal Chemistry Research 21, no. 11 (2012): 3396–405.
   Web of Science ®Google Scholar
• M. Shiradkar, G. V. S. Kumar, V. Dasari, S. Tatikonda, K. C. Akula, and R. Shah, “Clubbed Triazoles: A Novel Approach to Antitubercular Drugs,” European Journal of Medicinal Chemistry 42, no. 6 (2007): 807–16.
   PubMed Web of Science ®Google Scholar
• S. M. Gomha, and K. D. A. Khalil, “Convenient Ultrasound-Promoted Synthesis of Some New Thiazole Derivatives Bearing a Coumarin Nucleus and Their Cytotoxic Activity,” Molecules (Basel, Switzerland) 17, no. 8 (2012): 9335–47.
   PubMed Web of Science ®Google Scholar
• S. M. Gomha, T. A. Salah, and A. O. Abdelhamid, “Synthesis, Characterization, and Pharmacological Evaluation of Some Novel Thiadiazoles and Thiazoles Incorporating Pyrazole Moiety as Anticancer Agents,” Monatshefte Für Chemie - Chemical Monthly 146, no. 1 (2015): 149–58. 1007/s00706-014-1303-9.
   Google Scholar
• S. M. Gomha, S. M. Riyadh, I. M. Abbas, and M. A. Bauomi, “Synthetic Utility of Ethylidene Thiosemicarbazide: synthesis and anti-Cancer Activity of 1,3-Thiazines and Thiazoles with Imidazole Moiety,” Heterocycles 87, no. 2 (2013): 341.
   Web of Science ®Google Scholar
• S. M. Gomha, M. R. Abdelaziz, N. A. Kheder, H. M. Abdel-Aziz, S. Alterary, and Y. N. Mabkhot, “A Facile Access and Evaluation of Some Novel Thiazole and 1, 3, 4-Thiadiazole Derivatives Incorporating Thiazole Moiety as Potent Anticancer Agents,” Chemistry Central Journal 11, no. 1 (2017): 105.
   PubMedGoogle Scholar
• B. F. Abdel-Wahab, H. A. Abdel-Aziz, and E. M. Ahmed, “Synthesis and Antimicrobial Evaluation of 1-(Benzofuran-2-yl)-4-Nitro-3-Arylbutan-1-Ones and 3-(Benzofuran-2-yl)-4, 5-Dihydro-5-Aryl-1-[4-(Aryl)-1, 3-Thiazol-2-yl]-1H-Pyrazoles,” European Journal of Medicinal Chemistry 44, no. 6 (2009): 2632–5.
   PubMed Web of Science ®Google Scholar
• Abdou Osman Abdelhamid, Nadia Abdelhamid Abdel-Riheem, Tamer Tawhid El-Idreesy, and Huda Refat Mahmoud Rashdan, “Synthesis of 5-Arylazothiazoles, Pyridines and Thieno [2, 3-b] Pyridines Derivatives Containing 1, 2,3- Triazole Moiety,” European Journal of Chemistry 3, no. 3 (2012): 322–31.
   Google Scholar
• S. Ahmad, N. A. Abdelriheem, and A. Abdelhamid, “Cycloketones as Precursor for Convenient Synthesis of Azolopyrimidines and 5-Arylazothiazoles,” European Chemical Bulletin 3 (2014): 1038–45.
   Google Scholar
• E. Mansour, A. H. Taher, A. F. El-Farargy, and S. I. Elewa “Synthesis of Some Novel Indoline-2, 3-dione Derivatives and the Influence of Gamma irradiation on Their Biological Activities” Polycyclic aromatic compounds.(advance online puplication), Published online: 23 Oct, 2021. https://doi.org/10.1080/10406638.2021.1991395
   Google Scholar
• A. Verma, and S. K. Saraf, “4-thiazolidinone–a Biologically Active Scaffold,” European Journal of Medicinal Chemistry 43, no. 5 (2008): 897–905.
   PubMed Web of Science ®Google Scholar
• A. K. Jain, A. Vaidya, V. Ravichandran, S. K. Kashaw, and R. K. Agrawal, “Recent Developments and Biological Activities of Thiazolidinone Derivatives: A Review,” Bioorganic & Medicinal Chemistry 20, no. 11 (2012): 3378–95.
   PubMed Web of Science ®Google Scholar
• S. P. Singh, S. S. Parmar, K. Raman, and V. I. Stenberg, “Chemistry and Biological Activity of Thiazolidinones,” Chemical Reviews 81, no. 2 (1981): 175–203.
   Web of Science ®Google Scholar
• F. C. Brown, “4-Thiazolidinones,” Chemical Reviews 61, no. 5 (1961): 463–521.
   Web of Science ®Google Scholar
• N. B. Patel, and F. M. Shaikh, “Synthesis and Antimicrobial Activity of New 4- Thiazolidinone Derivatives Containing 2-Amino-6-Methoxybenzothiazole,” Saudi Pharmaceutical Journal : SPJ : The Official Publication of the Saudi Pharmaceutical Society 18, no. 3 (2010): 129–36.
   PubMedGoogle Scholar
• J. Hu, Y. Wang, X. Wei, X. Wu, G. Chen, G. Cao, X. Shen, X. Zhang, Q. Tang, G. Liang, and X. Li, “Synthesis and Biological Evaluation of Novel Thiazolidinone Derivatives as Potential anti-Inflammatory Agents,” European Journal of Medicinal Chemistry 64 (2013): 292–301.
   PubMed Web of Science ®Google Scholar
• K. Omar, A. Geronikaki, P. Zoumpoulakis, C. Camoutsis, M. Soković, A. Ćirić, and J. Glamočlija, “Novel 4-Thiazolidinone Derivatives as Potential Antifungal and Antibacterial Drugs,” Bioorganic & Medicinal Chemistry 18, no. 1 (2010): 426–32.
   PubMed Web of Science ®Google Scholar
• F. A. R. Ruiz, R. N. García-Sánchez, S. V. Estupiñan, A. Gómez-Barrio, D. F. T. Amado, B. M. Pérez-Solórzano, J. J. Nogal-Ruiz, A. R. Martínez-Fernández, and V. V. Kouznetsov, “Synthesis and Antimalarial Activity of New Heterocyclic Hybrids Based on Chloroquine and Thiazolidinone Scaffolds,” Bioorganic & Medicinal Chemistry 19, no. 15 (2011): 4562–73.
   PubMed Web of Science ®Google Scholar
• M. R. Shiradkar, M. Ghodake, K. G. Bothara, S. V. Bhandari, A. Nikalje, K. C. Akula, N. C. Desai, and P. J. Burange, “Synthesis and Anticonvulsant Activity of Clubbed Thiazolidinone–Barbituric Acid and Thiazolidinone–Triazole Derivatives,” Arkivoc 2007, no. 14 (2007): 58–74.
   Google Scholar
• Abdou O. Abdelhamid, Ibrahim E. El Sayed, Yasser H. Zaki, Ahmed M. Hussein, Mangoud M. Mangoud, and Mona A. Hosny, “Utility of 5 -(Furan-2 -yl)-3 -(p- Tolyl) -4,5-Dihydro -1H- Pyrazole-1-Carbothioamide in the Synthesis of Heterocyclic Compounds with Antimicrobial Activity,” BMC Chemistry 13, no. 1 (2019): 48.
   PubMedGoogle Scholar
• Rosaria Ottanà, Rosanna Maccari, Marco Giglio, Antonella Del Corso, Mario Cappiello, Umberto Mura, Sandro Cosconati, Luciana Marinelli, Ettore Novellino, Stefania Sartini, et al, “Identification of 5-Arylidene-4- Thiazolidinone Derivatives Endowed with Dual Activity as Aldose Reductase Inhibitors and Antioxidant Agents for the Treatment of Diabetic Complications,” European Journal of Medicinal Chemistry 46, no. 7 (2011): 2797–806.
   PubMed Web of Science ®Google Scholar
• K. J. Abhishek, V. Ankur, R. Veerasamy, K. K. Sushil A, and K. A. Ram, “Recent Developments and Biological Activities of Thiazolidinone Derivatives: A Review,” Bioorganic & Medicinal Chemistry 1 (2012): 3378–95.
   Google Scholar
• R. A. Kabli, A. A. Khalaf, M. T. Zimaity, A. M. Khalil, A. M. Kaddah, and H. A. Al-Rifaie, “Synthesıs of a New Serıes of Furyl and Thıenyl Substıtuted Pyrazolınes Startıng Wıth Furyl and Thıenyl Chalcones,” Journal of the Indian Chemical Society. 68 (1991): 47–51.
   Web of Science ®Google Scholar
• RICHARD H. Wiley, C. H. Jarboe, F. N. Hayes, E. Hansbury, J. T. Nielsen, P. X. Callahan, and M. C. Sellars, “1,3,5-Triaryl-2-Pyrazolines for Use as Scintillation Solutes,” The Journal of Organic Chemistry 23, no. 5 (1958): 732–8.
   Web of Science ®Google Scholar
• A. Romdhane, and H. Jannet, “Synthesis of New Pyran and Pyranoquinolne,” Arabian Journal.of Chemistry 10 (2017): S3128–S3134.
   Web of Science ®Google Scholar
• C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney, “Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development settings1PII of Original Article: S0169-409X(96)00423-1,” Advanced Drug Delivery Reviews 23, no. 1-3 (1997): 3–25.1. Advanced Drug Delivery Reviews. 46 (2001): 3–26. https://doi.org/10.1016/S0169-409X(00)00129-0.
   Web of Science ®Google Scholar
• C. A. Lipinski, “Lead- and Drug-like Compounds ‘‘the Rule-of-Five Revolution,” Drug Discovery Today. Technologies 1, no. 4 (2004): 337–41. https://doi.org/10.1016/j.ddtec.2004.11.007.
   PubMedGoogle Scholar
• T. A. Chohan, H. Qian, Y. Pan, and J.-Z. Chen, “Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as anti-Cancer Agents,” Current Medicinal Chemistry 22, no. 2 (2015): 237–63. https://doi.org/10.2174/0929867321666141106113633.
   PubMed Web of Science ®Google Scholar
• M. S. Nafie, M. A. Tantawy, and G. A. Elmgeed, “Screening of Different Drug Design Tools to Predict the Mode of Action of Steroidal Derivatives as anti-Cancer Agents,” Steroids 152 (2019): 108485. https://doi.org/10.1016/j.steroids.2019.108485.
   PubMed Web of Science ®Google Scholar
• A. T. A. Boraei, E. H. Eltamany, I. A. I. Ali, S. M. Gebriel, and M. S. Nafie, “Synthesis of New Substituted Pyridine Derivatives as Potent anti-Liver Cancer Agents through Apoptosis Induction: In Vitro, in Vivo, and in Silico Integrated Approaches,” Bioorganic Chemistry 111 (2021): 104877. https://doi.org/10.1016/j.bioorg.2021.104877.
   PubMed Web of Science ®Google Scholar